Tumor cytostatic-citocidal factor from blood platelets

Drug – bio-affecting and body treating compositions – Fermentate of unknown chemical structure – Having a known elemental analysis

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514 2, A61K 3514

Patent

active

046769838

ABSTRACT:
A tumor cytostatic-cytocidal factor is produced by disrupting platelets, extracting the disrupted platelets with an acidic aqueous solution or an acidic water-organic solvent mixture, and, after gel filtration, if desired, to separate a fraction having an estimated molecular weight of 10,000 to 20,000 and having tumor cell growth inhibiting activity, subjecting said extract or said fraction to chromatography to isolate a cytostatic fraction having a molecular weight of 10,000 to 20,000 and an isoelectric point of 9.0 to 10.0, giving a positive nihidrin reaction and being such that it is deactivated by trypsin but not deactivated by heating in physiological saline solution at 60.degree. C. for 30 minutes or contacting at room temperature with 0.2N hydrochloric acid for 60 minutes or 70% formic acid for 30 minutes.

REFERENCES:
Hara et al.-Chem. Abst. vol. 92 (1980), p. 196,061n.
Witkoski-Chem. Abst. vol. 97 (1982), p. 139,965q.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Tumor cytostatic-citocidal factor from blood platelets does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tumor cytostatic-citocidal factor from blood platelets, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tumor cytostatic-citocidal factor from blood platelets will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-447013

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.